首站-论文投稿智能助手
典型文献
Al-empowered integrative structural characterization of m6A methyltransferase complex
文献摘要:
Dear Editor, N6-methyladenosine(m6A)is the most abundant and prevalent internal modification in mRNA.1 In mammals,m6A exerts pivotal roles in posttranscriptional regulation and its dysregulation is implicated in various diseases including cancer.2 m6A is installed by a multicomponent methyltransferase complex(MTC,also known as the m6A writer complex).
文献关键词:
作者姓名:
Xuhui Yan;Kai Pei;Zeyuan Guan;Feiqing Liu;Junjun Yan;Xiaohuan Jin;Qiang Wang;Mengjun Hou;Chun Tang;Ping Yin
作者机构:
National Key Laboratory of Crop Genetic Improvement,Hubei Hongshan Laboratory Huazhong Agricultural University,Wuhan,Hubei,China;Beijing National Laboratory for Molecular Sciences,College of Chemistry and Molecular Engineering,PKU-Tsinghua Center for Life Sciences,Center for Quantitative Biology,Peking University,Beijing,China
引用格式:
[1]Xuhui Yan;Kai Pei;Zeyuan Guan;Feiqing Liu;Junjun Yan;Xiaohuan Jin;Qiang Wang;Mengjun Hou;Chun Tang;Ping Yin-.Al-empowered integrative structural characterization of m6A methyltransferase complex)[J].细胞研究(英文版),2022(12):1124-1127
A类:
N6
B类:
empowered,integrative,structural,characterization,m6A,methyltransferase,complex,Dear,Editor,methyladenosine,most,abundant,prevalent,internal,modification,In,mammals,exerts,pivotal,roles,posttranscriptional,its,dysregulation,implicated,various,diseases,including,cancer,installed,by,multicomponent,MTC,also,known,writer
AB值:
0.69356
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
Ruixuan Chen;Ping Ouyang;Licong Su;Xi Xu;Penghu Lian;Yanqin Li;Qi Gao;Yifan Zhang;Sheng Nie;Fan Luo;Ruqi Xu;Xiaodong Zhang;Xiaoxi Li;Yue Cao;Peiyan Gao;Juanjuan Kang;Jun Wu;Lu Li-National Clinical Research Center for Kidney Disease,State Key Laboratory of Organ Failure Research,Guangdong Provincial Clinical Research Center for Kidney Disease,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Health Management,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Hematology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Department of Urology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College(CAMS&PUMC),Beijing 100730,China;Department of Urology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China;Affiliated Foshan Maternity&Child Healthcare Hospital,Southern Medical University,Foshan 528000,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou 510000,China
FTO stabilizes MIS12 and counteracts senescence
Sheng Zhang;Zeming Wu;Yue Shi;Si Wang;Jie Ren;Zihui Yu;Daoyuan Huang;Kaowen Yan;Yifang He;Xiaoqian Liu;Qianzhao Ji;Beibei Liu;Zunpeng Liu;Jing Qu;Guang-Hui Liu;Weimin Ci;Xiaoqun Wang;Weiqi Zhang-State Key Laboratory of Brain and Cognitive Science,CAS Center for Excellence in Brain Science and Intelligence Technology,Institute of Brain-Intelligence Technology(Shanghai),Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Advanced Innovation Center for Human Brain Protection,and National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,International Center for Aging and Cancer,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Chongqing Renji Hospital,University of Chinese Academy of Sciences,Chongqing 400062,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Brain Disorders,Beijing 100069,China
Loss of Wtap results in cerebellar ataxia and degeneration of Purkinje cells
Yeming Yang;Guo Huang;Xiaoyan Jiang;Xiao Li;Kuanxiang Sun;Yi Shi;Zhenglin Yang;Xianjun Zhu-The Sichuan Provincial Key Laboratory for Human Disease Gene Study and Department of Laboratory Medicine,Center for Medical Genetics,Sichuan Provincial People's Hospital,University of Electronic Science and Technology of China,Chengdu,Sichuan 610072,China;Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences(2019RU026),Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital,Chengdu,Sichuan 610072,China;Key Laboratory of Tibetan Medicine Research,Chinese Academy of Sciences and Qinghai Provincial Key Laboratory of Tibetan Medicine Research,Northwest Institute of Plateau Biology,Xining,Qinghai 810008,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。